{
    "Trade/Device Name(s)": [
        "Audit\u2122M MicroCVTM ASO Linearity Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K100750",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MJX"
    ],
    "Summary Letter Date": "March 12, 2010",
    "Summary Letter Received Date": "March 16, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Anti-streptolysin O (ASO)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Vial"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Assay",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u2122M MicroCVTM ASO Linearity Set, a five-level human serum QC material for linearity testing of Anti-streptolysin O (ASO) assays",
    "Indications for Use Summary": "Intended to simulate human patient serum for monitoring precision and detecting analytical deviations in laboratory testing procedures for Anti-streptolysin O (ASO); may be used as assayed or unassayed quality control material",
    "fda_folder": "Clinical Chemistry"
}